Today, the US House of Representatives passed the Build Back Better Act, which includes a $35 per month insulin co-pay cap for people with Medicare, employer-sponsored coverage, or insurance bought on the ACA marketplace.

JDRF celebrates passage of the co-pay cap, and other provisions that address insulin affordability, as they represent significant steps forward to address this ongoing crisis.

JDRF urges the Senate to include these provisions and do their part to make insulin more affordable for the millions of Americans with diabetes who need insulin to survive, including 1.6 million with T1D.